Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Intravenous Nitrite Infusion for Reversal of Cerebral Vasospasm After Subarachnoid Hemorrhage From a Cerebral Aneurysm

NCT02176837 is registered in ClinicalTrials.gov with Hope Pharmaceuticals as lead sponsor.

NCT NCT02176837
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02176837 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Intravenous Nitrite Infusion for Reversal of Cerebral Vasospasm After Subarachnoid Hemorrhage From a Cerebral Aneurysm
Lead sponsor
Hope Pharmaceuticals
Phase
Phase 2
Overall status
Terminated
Start date
June 30, 2014
Completion date
January 15, 2017
Enrollment
6 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

subarachnoid hemorrhage